ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity
Open Access
- 20 November 2024
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 203, 106741
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Obesity-associated microglial inflammatory activation paradoxically improves glucose toleranceCell Metabolism, 2023
- Emerging roles of innate and adaptive immunity in Alzheimer’s diseaseImmunity, 2022
- Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic miceMetabolic Brain Disease, 2022
- Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathologyCell Reports, 2021
- Obesity and aging: Molecular mechanisms and therapeutic approachesAgeing Research Reviews, 2021
- Crosstalk between obesity, diabetes, and alzheimer’s disease: Introducing quercetin as an effective triple herbal medicineAgeing Research Reviews, 2020
- Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiotaDiabetologia, 2018
- Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patientsArchives of Gerontology and Geriatrics, 2010
- Alzheimer's disease: Isoproterenol and prostaglandin E1-stimulated cyclic AMP accumulation in lymphocytesLife Sciences, 1984